Evidence map›Paper›PMID 36504293›Full record

ArticleCancer2023

Patterns of failure in pediatric medulloblastoma and implications for hippocampal sparing.

Sujith Baliga, Judith A Adams, Benjamin V M Bajaj, Liam Van Benthuysen, Juliane Daartz, Sara L Gallotto, Jacqueline R Lewy, Nicholas DeNunzio, Elizabeth A Weyman, Miranda P Lawell and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 1 country.

Sujith BaligaDepartment of Radiation Oncology, Ohio State University Wexner Medical Center, Columbus, Ohio, USA.ORCID 0000-0002-8032-2071
Judith A AdamsDepartment of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA.
Benjamin V M BajajDepartment of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA.
Liam Van BenthuysenDepartment of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA.
Juliane DaartzDepartment of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA.
Sara L GallottoDepartment of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA.
Jacqueline R LewyDepartment of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA.
Nicholas DeNunzioDepartment of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA.
Elizabeth A WeymanDepartment of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA.
Miranda P LawellDepartment of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA.
Joshua D PalmerDepartment of Radiation Oncology, Ohio State University Wexner Medical Center, Columbus, Ohio, USA.ORCID 0000-0003-3311-0129
Beow Y YeapDepartment of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA.
David H EbbDepartment of Pediatric Hematology Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Mary S HuangDepartment of Pediatric Hematology Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Alisa F PerryDepartment of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA.
Shannon M MacDonaldDepartment of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA.
Robin M JonesDepartment of Pediatric Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Nancy J TarbellDepartment of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA.
Torunn I YockDepartment of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA.
Harvard University · USMassachusetts General Hospital · USThe Ohio State University Wexner Medical Center · US

Funding

PROTON THERAPY RESEARCH AND TREATMENT CENTERC06CA059267 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI GOITEIN, MICHAEL · 1992 to 1995
–
NCI NIH HHS C06 CA059267
6 · The paper itself

Abstract

backgroundHippocampal avoidance (HA) has been shown to preserve cognitive function in adult patients with cancer treated with whole-brain radiation therapy for brain metastases. However, the feasibility of HA in pediatric patients with brain tumors has not been explored because of concerns of increased risk of relapse in the peri-hippocampal region. Our aim was to determine patterns of recurrence and incidence of peri-hippocampal relapse in pediatric patients with medulloblastoma (MB). METHODS AND MATERIALS: We identified pediatric patients with MB treated with protons between 2002 and 2016 and who had recurrent disease. To estimate the risk of peri-hippocampal recurrence, three hippocampal zones (HZs) were delineated corresponding to ≤5 mm (HZ-1), 6 to 10 mm (HZ-2), and >10 mm (HZ-3) distance of the recurrence from the contoured hippocampi. To determine the feasibility of HA, three standard-risk patients with MB were planned using either volumetric-modulated arc therapy (VMAT) or intensity-modulated proton therapy (IMPT) plans.

resultsThirty-eight patients developed a recurrence at a median of 1.6 years. Of the 25 patients who had magnetic resonance imaging of the recurrence, no patients failed within the hippocampus and only two patients failed within HZ-1. The crude incidence of peri-hippocampal failure was 8%. Both HA-VMAT and HA-IMPT plans were associated with significantly reduced mean dose to the hippocampi (p < .05). HA-VMAT and HA-IMPT plans were associated with decreased percentage of the third and lateral ventricles receiving the prescription craniospinal dose of 23.4 Gy.

conclusionsPeri-hippocampal failures are uncommon in pediatric patients with MB. Hippocampal avoidance should be evaluated in a prospective cohort of pediatric patients with MB. PLAIN LANGUAGE SUMMARY: In this study, the patterns of disease recurrence in patients with a pediatric brain tumor known as medulloblastoma treated with proton radiotherapy were examined. The majority of failures occur outside of an important structure related to memory formation called the hippocampus. Hippocampal sparing radiation plans using proton radiotherapy were generated and showed that dose to the hippocampus was able to be significantly reduced. The study provides the rationale to explore hippocampal sparing in pediatric medulloblastoma in a prospective clinical trial.

Indexed as

Brain NeoplasmsCerebellar NeoplasmsMedulloblastomaRadiotherapy, Intensity-ModulatedChildCranial IrradiationHippocampusHumansNeoplasm Recurrence, LocalOrgans at RiskOrgan Sparing TreatmentsProspective StudiesProtonsRadiotherapy DosageRadiotherapy Planning, Computer-AssistedProtonshippocampal sparinglate effectsmedulloblastomaneurocognitive sparingproton radiation

Identifiers

PMID36504293
PMCPMC10107770
OpenAlexW4311130759

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.